PPA
GILD icon

Parametric Portfolio Associates’s Gilead Sciences GILD Stock Holding History

Parametric Portfolio Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$210M Sell
3,534,074
-756,092
-18% -$48.3M 0.11% 171
2021
Q4 		$312M Buy
4,290,166
+220,141
+5% +$15.2M 0.16% 106
2021
Q3 		$284M Sell
4,070,025
-2,587,674
-39% -$182M 0.16% 109
2021
Q2 		$458M Buy
6,657,699
+98,987
+2% +$6.61M 0.26% 70
2021
Q1 		$424M Buy
6,558,712
+293,660
+5% +$18.9M 0.24% 65
2020
Q4 		$365M Buy
6,265,052
+338,612
+6% +$20.4M 0.23% 66
2020
Q3 		$374M Buy
5,926,440
+153,979
+3% +$10.7M 0.27% 61
2020
Q2 		$444M Buy
5,772,461
+441,749
+8% +$33.9M 0.34% 51
2020
Q1 		$399M Buy
5,330,712
+683,991
+15% +$47.3M 0.36% 42
2019
Q4 		$302M Sell
4,646,721
-154,718
-3% -$10.1M 0.22% 79
2019
Q3 		$304M Buy
4,801,439
+57,705
+1% +$3.77M 0.25% 68
2019
Q2 		$320M Buy
4,743,734
+526,146
+12% +$34.6M 0.26% 61
2019
Q1 		$274M Buy
4,217,588
+78,552
+2% +$5.22M 0.24% 71
2018
Q4 		$259M Sell
4,139,036
-132,103
-3% -$9.23M 0.26% 63
2018
Q3 		$330M Buy
4,271,139
+272,906
+7% +$20.6M 0.29% 59
2018
Q2 		$283M Sell
3,998,233
-158,526
-4% -$11.2M 0.27% 60
2018
Q1 		$313M Buy
4,156,759
+271,674
+7% +$21.6M 0.31% 49
2017
Q4 		$278M Buy
3,885,085
+347,349
+10% +$26.4M 0.28% 56
2017
Q3 		$287M Buy
3,537,736
+474,106
+15% +$36.3M 0.31% 52
2017
Q2 		$217M Buy
3,063,630
+843,143
+38% +$56.1M 0.26% 64
2017
Q1 		$151M Sell
2,220,487
-1,079,090
-33% -$75.9M 0.23% 62
2016
Q4 		$236M Buy
3,299,577
+287,089
+10% +$21.3M 0.33% 49
2016
Q3 		$238M Sell
3,012,488
-97,050
-3% -$7.88M 0.36% 46
2016
Q2 		$259M Buy
3,109,538
+94,597
+3% +$8.4M 0.41% 40
2016
Q1 		$277M Sell
3,014,941
-343,991
-10% -$31M 0.45% 35
2015
Q4 		$340M Buy
3,358,932
+57,541
+2% +$5.99M 0.58% 26
2015
Q3 		$324M Buy
3,301,391
+566,541
+21% +$62.9M 0.63% 23
2015
Q2 		$320M Buy
2,734,850
+102,433
+4% +$11.2M 0.63% 16
2015
Q1 		$258M Buy
2,632,417
+172,037
+7% +$17.5M 0.52% 26
2014
Q4 		$232M Sell
2,460,380
-149,041
-6% -$15.4M 0.49% 33
2014
Q3 		$278M Sell
2,609,421
-75,702
-3% -$7.41M 0.61% 20
2014
Q2 		$223M Sell
2,685,123
-84,059
-3% -$6.54M 0.5% 25
2014
Q1 		$196M Buy
2,769,182
+80,654
+3% +$6.33M 0.47% 32
2013
Q4 		$202M Buy
2,688,528
+61,195
+2% +$4.26M 0.49% 29
2013
Q3 		$165M Buy
2,627,333
+72,833
+3% +$4.35M 0.45% 32
2013
Q2 		$131M Buy
+2,554,500
New +$133M 0.38% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametric Portfolio Associates's GILD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Gilead Sciences (GILD) stake by 18% in Q1 2022, selling an estimated $48.3M and leaving 3,534,074 shares worth $210M. The position accounts for 0.11% of the portfolio, ranked #171.

Parametric Portfolio Associates first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $458M in Q2 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Parametric Portfolio Associates held 3,534,074 shares of Gilead Sciences worth $210M as of Q1 2022.
  • Parametric Portfolio Associates sold 756,092 Gilead Sciences shares in Q1 2022, an estimated $48.3M.
  • Gilead Sciences made up 0.11% of Parametric Portfolio Associates's portfolio in Q1 2022, its #171 holding.
  • Parametric Portfolio Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Gilead Sciences position peaked at $458M in Q2 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.